DOP16: Categorizing endoscopic severity of Crohn’s Disease using the Modified Multiplier SES-CD (MM-SES-CD)ECCO'22Year: 2022
Authors: Narula, N.(1);Pray, C.(1);Wong, E.(1);Colombel, J.F.(2);Marshall, J.(1);Daperno, M.(3);Reinisch, W.(4);Dulai, P.(5);
(1)McMaster University, Department of Medicine Division of Gastroenterology, Hamilton, Canada;(2)Icahn School of Medicine at Mount Sinai, Division of Gastroenterology, New York, United States;(3)AO Ordine Mauriziano di Torino, Gastroenterology Unit, Turin, Italy;(4)Medical University of Vienna, Department of Internal Medicine III Division of Gastroenterology and Hepatology, Vienna, Austria;(5)University of California San Diego, Division of Gastroenterology, La Jolla, United States;
DOP17: Evaluating segmental healing with the modified Mayo endoscopic score (MMES) has a clear additional value in predicting long-term outcome in patients with Ulcerative Colitis: Results from a prospective cohort studyECCO'22Year: 2022
Authors: Lenfant, M.(1,2);Verstockt, B.(1,2);Sabino, J.(1,2);Vermeire, S.(1,2);Ferrante, M.(1,2);
(1)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(2)KU Leuven, Translational Research in Gastrointestinal Disorders, Leuven, Belgium;
DOP18: Advanced optical diagnosis technology for assessment of endoscopic and histological remission in Ulcerative Colitis: A systematic review and meta-analysisECCO'22Year: 2022
Authors: Nardone, O.M.(1);Snir , Y.(2,3);Hodson, J.(4);Cannatelli, R.(1);Labarile, N.(1);Siau, K.(1,5);Hassan, C.(6);Yanai, H.(2,3);Dotan, I.(2,3);Ghosh, S.(1,7,8,9);Iacucci, M.(1,8,9);
(1)University of Birmingham, Institute of Translational Medicine and Institute of Immunology and Immunotherapy, Birmingham, United Kingdom;(2)Rabin Medical Center- Beilinson Campus- Petach-Tikva Israel, Division of Gastroenterology, Petach-Tikva, Israel;(3)Tel Aviv University- Tel Aviv- Israel, Sackler Faculty of Medicine, Tel Aviv, Israel;(4)University Hospitals Birmingham NHS Foundation Trust- Birmingham- UK., Department of Health Informatics-, Birmingham, United Kingdom;(5)Royal Cornwall Hospitals NHS Trust- Truro- UK, Department of Gastroenterology-, Truro, United Kingdom;(6)Nuovo Regina Margherita Hospital- Roma- Italy, Department of Gastroenterology, Rome, Italy;(7)University College Cork- Cork- Ireland, APC Microbiome Ireland- College of Medicine and Health, Cork, Ireland;(8)University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, NIHR Biomedical Research Centre, Birmingham, United Kingdom;(9)University Hospitals Birmingham NHS Trust- Birmingham- UK, NIHR Wellcome Trust Clinical Research Facilities, Birmingham, United Kingdom;
DOP19: Myeloid and lymphoid cell abnormalities persist in the intestinal mucosa of patients who recover from COVID-19 infectionECCO'22Year: 2022
Authors: Meringer, H.(1);Tokuyama, M.(1);Tankelevich, M.(1);Martinez-Delgado, G.(1);Jha, D.(1); Livanos, A.E.(1);Canales-Herrerias, P.(1);Cossarini, F.(2);Mehandru , S.(1);
(1)Icahn School of medicine at Mount Sinai, Division of Gastroenterology- Department of Medicine, New York, United States;(2)Icahn School of medicine at Mount Sinai, Division of Infectious Disease- Department of Medicine, New York, United States;
DOP20: Functional viral neutralisation responses after SARS-CoV-2 infection in Inflammatory Bowel Disease patients receiving infusion therapies: Report from the ICARUS-IBD ConsortiumECCO'22Year: 2022
Authors: Wellens, J.(1,2);Edmans, M.(3);Obolski, U.(4,5);Marlow, L.(1);Brann, S.(1);Dunachie, S.(3,6,7);Eyre, D.(8,9);Helmus, D.(10);Barnes, E.(1,3);Colombel, J.F.(10);Wong, S.Y.(10);Klenerman, P.(1,3);Lindsay, J.O.(11,12);Thompson, C.P.(13);Satsangi, J.(1);
(1)University of Oxford, Translational Gastro-Intestinal Unit- Nuffield Department of Medicine, Oxford, United Kingdom;(2)University hospitals Leuven, Translational Research for Gastrointestinal Diseases, Leuven, Belgium;(3)University of Oxford, Peter Medawar Building for Pathogen Research, Oxford, United Kingdom;(4)Tel-Aviv University, Porter School of Environmental and Earth Sciences- Faculty of Exact Sciences, Tel-Aviv, Israel;(5)Tel-Aviv University, School of Public Health- Faculty of Medicine, Tel-Aviv, Israel;(6)Oxford University Hospitals- NHS, Department of Microbiology/Infectious Diseases, Oxford, United Kingdom;(7)University of Oxford, Centre for Tropical Medicine and Global Health- Nuffield Department of Medicine, Oxford, United Kingdom;(8)University of Oxford, Big Data Institute, Oxford, United Kingdom;(9)University of Oxford, Infectious Diseases & Medical Microbiology, Oxford, United Kingdom;(10)Icahn School of Medicine at Mount Sinai- New York, The Henry D. Janowitz Division of Gastroenterology- Department of Medicine, New York, United States;(11)The Royal London Hospital, Barts Health NHS Trust- department of Gastroenterology, London, United Kingdom;(12)Blizard Institute- Barts and the London School of Medicine Queen Mary University of London, Centre for Immunobiology, London, United Kingdom;(13)University of Oxford, Department of Zoology, Oxford, United Kingdom;The ICARUS-IBD CONSORTIUM
DOP21: Potential mechanisms linking biological therapies on SARS-CoV-2 susceptibility in Inflammatory Bowel Disease patientsECCO'22Year: 2022
Authors: Pisani, L.F.(1);Mola, S.(2,3);Crespi, G.(2,3);Caprioli, F.(4,5);Pastorelli, L.(6,7);Annunziata, M.L.(1);Manfredi, M.(3,8);Porta, C.(2,3);
(1)IRCCS Policlinico San Donato, Gastroenterology and Endoscopy Unit, San Donato Milanese, Italy;(2)University of Piemonte Orientale, Department of Pharmaceutical Sciences, Novara, Italy;(3)University of Piemonte Orientale, Center for Translational Research on Autoimmune and Allergic Diseases, Novara, Italy;(4)University of Milan, Department of Medical-Surgical Physiopathology and Transplantation, Milan, Italy;(5)Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Gastroenterology and Endoscopy Unit, Milan, Italy;(6)University of Milan, Department of Health Sciences, Milan, Italy;(7)ASST Santi Paolo e Carlo, Gastroenterology and Liver Unit, Milan, Italy;(8)University of Piemonte Orientale, Department of Translational Medicine, Novara, Italy;
DOP22: Clinical, biochemical and endoscopic disease activity of Inflammatory Bowel Diseases are not associated with the severity or long-term outcomes of COVID-19 – A Danish prospective population-based cohort studyECCO'22Year: 2022
Authors: Attauabi, M.(1,2,3);Dahlerup, J.F.(4);Poulsen, A.(5);Hansen, M.R.(6);Vester-Andersen, M.K.(7);Eraslan, S.(2);Prahm, A.P.(5);Pedersen, N.(8);Larsen, L.(9);Jess, T.(9,10);Neumann, A.(11);Haderslev, K.V.(12);Molazahi, A.(13);Lødrup, A.B.(14);Glerup, H.(15);Oppfeldt, A.M.(16);Jensen, M.D.(17);Theede, K.(1,3);Kiszka-Kanowitz, M.(1,3);Seidelin, J.B.(2);Burisch, J.(1,3); Danish COVID-IBD Study Group
(1)Copenhagen University Hospital- Hvidovre, Gastrounit- Medical Section, Hvidovre, Denmark;(2)Herlev Hospital- University of Copenhagen, Department of Gastroenterology and Hepatology, Herlev, Denmark;(3)University of Copenhagen- Hvidovre Hospital, Copenhagen Center for Inflammatory Bowel Disease in Children- Adolescents and Adults, Hvidovre, Denmark;(4)Aarhus University Hospital, Department of Hepatology and Gastroenterology, Aarhus, Denmark;(5)Bispebjerg University Hospital, Digestive Disease Center, Copenhagen, Denmark;(6)North Zealand University Hospital, Department of Gastroenterology, Frederikssund, Denmark;(7)Zealand University Hospital- Koege, Department of Internal Medicine, Koege, Denmark;(8)Slagelse Hospital, Department of Gastroenterology, Slagelse, Denmark;(9)Aalborg University Hospital, Department of Gastroenterology and Hepatology, Aalborg, Denmark;(10)Aalborg University, National Center of Excellence for Molecular Prediction of Inflammatory Bowel Disease PREDICT- Department of Clinical Medicine, Copenhagen, Denmark;(11)Region Hospital Viborg, Department of Internal Medicine, Viborg, Denmark;(12)Rigshospitalet- Copenhagen University Hospital, Department of Gastroenterology, Copenhagen, Denmark;(13)Holbaek Hospital, Department of Internal Medicine, Holbaek, Denmark;(14)Region Hospital West Jutland- Herning, Department of Internal Medicine, Herning, Denmark;(15)Region Hospital Silkeborg, Department of Internal Medicine, Silkeborg, Denmark;(16)Region Hospital Horsens, Department of Internal Medicine, Horsens, Denmark;(17)Lillebaelt Hospital- Vejle, Department of Internal Medicine- Section of Gastroenterology, Vejl, Denmark;
DOP23: Long-term health consequences of COVID-19 in patients with Inflammatory Bowel Diseases – A Danish prospective population-based cohort studyECCO'22Year: 2022
Authors: Attauabi, M.(1,2,3);Dahlerup, J.F.(4);Poulsen, A.(5);Hansen, M.R.(6);Vester-Andersen, M.K.(7);Eraslan, S.(2);Prahm, A.P.(5);Pedersen, N.(8);Larsen, L.(9);Jess, T.(9,10);Neumann, A.(11);Haderslev, K.V.(12);Molazahi, A.(13);Lødrup, A.B.(14);Glerup, H.(15);Oppfeldt, A.M.(16);Jensen, M.D.(17);Theede, K.(1,3);Kiszka-Kanowitz, M.(1,3);Seidelin, J.B.(2);Burisch, J.(1,3); Danish COVID-IBD Study Group
(1)Copenhagen University Hospital- Hvidovre, Gastrounit- Medical Section, Hvidovre, Denmark;(2)Herlev Hospital- University of Copenhagen, Department of Gastroenterology and Hepatology, Herlev, Denmark;(3)University of Copenhagen- Hvidovre Hospital, Copenhagen Center for Inflammatory Bowel Disease in Children- Adolescents and Adults, Hvidovre, Denmark;(4)Aarhus University Hospital, Department of Hepatology and Gastroenterology, Aarhus, Denmark;(5)Bispebjerg University Hospital, Digestive Disease Center, Copenhagen, Denmark;(6)North Zealand University Hospital, Department of Gastroenterology, Frederikssund, Denmark;(7)Zealand University Hospital- Koege, Department of Internal Medicine, Koege, Denmark;(8)Slagelse Hospital, Department of Gastroenterology, Slagelse, Denmark;(9)Aalborg University Hospital, Department of Gastroenterology and Hepatology, Aalborg, Denmark;(10)Aalborg University, National Center of Excellence for Molecular Prediction of Inflammatory Bowel Disease PREDICT- Department of Clinical Medicine, Copenhagen, Denmark;(11)Region Hospital Viborg, Department of Internal Medicine, Viborg, Denmark;(12)Rigshospitalet- Copenhagen University Hospital, Department of Gastroenterology, Copenhagen, Denmark;(13)Holbaek Hospital, Department of Internal Medicine, Holbaek, Denmark;(14)Region Hospital West Jutland- Herning, Department of Internal Medicine, Herning, Denmark;(15)Region Hospital Silkeborg, Department of Internal Medicine, Silkeborg, Denmark;(16)Region Hospital Horsens, Department of Internal Medicine, Horsens, Denmark;(17)Lillebaelt Hospital, Department of Internal Medicine- Section of Gastroenterology, Vejle, Denmark;
DOP24: Japan prospective multicenter study for optimization of COVID-19 vaccinations based on the immune response and safety profile in Inflammatory Bowel Disease patients: Interim analyses of the J-COMBAT trialECCO'22Year: 2022
Authors: WatanabeDirector of division- Assistan, K.(1);Hisamatsu, T.(2);Nakase, H.(3);Nagase, K.(1);Matsuura, M.(2);Aoyama, N.(4);Kobayashi, T.(5);Sakuraba, H.(6);Yokoyama, K.(7);Nishishita, M.(8);Esaki , M.(9);Hirai, F.(10);Nagahori, M.(11);Nanjo, S.(12);Omori, T.(13);Tanida, S.(14);Yokoyama, Y.(3);Moriya, K.(15);Maemoto, A.(16);Handa, O.(17);Ohmiya, N.(18);Shinzaki, S.(19);Kato, S.(20);Tanaka, H.(21);Uraoka, T.(22);Takatsu, N.(23);Suzuki, H.(24);Takahashi, K.(25);Umeno, J.(26);Mishima, Y.(27);Tsuchida, K.(28);Fujiya, M.(29);Hiraoka, S.(30);Yamamoto, S.(31);Saruta, M.(32);Nojima, M.(33);Andoh, A.(25);
(1)Hyogo College of Medicine, Center for Inflammatory Bowel Disease- Division of Internal Medicine, Hyogo, Japan;(2)Kyorin University School of Medicine, Department of Gastroenterology and Hepatology, Tokyo, Japan;(3)Sapporo Medical University School of Medicine, Gastroenterology and Hepatology, Sapporo, Japan;(4)Aoyama Medical Clinic, Gastroenterology, Kobe, Japan;(5)Kitasato University Kitasato Institute Hospital, Center for Advanced IBD Research and Treatment, Tokyo, Japan;(6)Hirosaki University Graduate School of Medicine, Gastroenterology and Hematology, Hirosaki, Japan;(7)Kitasato University School of Medicine, Department of Gastroenterology, Sagamihara, Japan;(8)Nishishita GI Hospital, Gastroenterology, Osaka, Japan;(9)Saga University, Division of Gastroenterology- Department of Internal Medicine, Saga, Japan;(10)Faculty of Medicine Fukuoka University, Gastroenterology, Fukuoka, Japan;(11)Tokyo Medical and Dental University Hospital, Gastroenterology and Hepatology, Tokyo, Japan;(12)University of Toyama, Third Department of Internal Medicine- Graduate School of Medicine, Toyama, Japan;(13)Tokyo Women’s Medical University, Institute of Gastroenterology, Tokyo, Japan;(14)Nagoya City University, Gastroenterology and Metabolism, Nagoya, Japan;(15)Nara Medical University, Department of Gastroenterology and Hepatology, Kashihara, Japan;(16)Sapporo Higashi Tokushukai Hospital, Inflammatory Bowel Disease Center, Sapporo, Japan;(17)Kawasaki Medical School, Internal Medicine- Division of Gastroenterology, Kurashiki, Japan;(18)Fujita Health University, Department of Advanced Endoscopy, Toyoake, Japan;(19)Osaka University Graduate School of Medicine, Gastroenterology and Hepatology, Suita, Japan;(20)Saitama Medical Center- Saitama Medical University, Department of Gastroenterology and Hepatology, Kawagoe, Japan;(21)Sapporo IBD Clinic, Inflammatory Bowel Disease, Sapporo, Japan;(22)Gunma University Graduate School of Medicine, Department of Gastroenterology and Hepatology, Maebashi, Japan;(23)Fukuoka University Chikushi Hospital, Inflammatory bowel disease center, Chikushino, Japan;(24)Faculty of Medicine- University of Tsukuba, Gastroenterology, Tsukuba, Japan;(25)Shiga University of Medical Science, Gastroenterology, Otsu, Japan;(26)Kyushu University, Medicine and Clinical Science- Graduate School of Medical Sciences Graduate School of Medical Sciences, Fukuoka, Japan;(27)Shimane University Faculty of Medicine, Department of Internal Medicine II, Izumo, Japan;(28)Nagoya City University West Medical Center, Gastroenterology, Nagoya, Japan;(29)Asahikawa Medical University, Department of Medicine, Asahikawa, Japan;(30)Okayama University Graduate School of Medicine- Dentistry and Pharmaceutical Sciences, Gastroenterology and Hepatology, Okayama, Japan;(31)Graduate School of Medicine- Kyoto University, Department of Gastroenterology and Hepatology, Kyoto, Japan;(32)The Jikei University School of Medicine, Division of Gastroenterology and Hepatology- Department of Internal Medicine, Tokyo, Japan;(33)The University of Tokyo, The Institute of Medical Science, Tokyo, Japan;J-COMBAT trial group
DOP25: Clinical outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel DiseaseECCO'22Year: 2022
Authors: Wetwittayakhlang, P.(1);Albader, F.(2);Golovics, P.(1);Drügg Hahn, G.(1);Bessissow, T.(1); Bitton, A.(1); Afif, W.(1);Wild, G.(1);LakatosPhD, P.L.(1); Inflammatory bowel disease McGill University Health Centre
(1)Mcgill University Health Center, IBD Centre, Montréal, Canada;(2)Mcgill University Health Center, Division of Internal Medicine, Montréal, Canada;
DOP26: COVID-19 vaccine effectiveness in Inflammatory Bowel Disease patients on tumor-necrosis factor inhibitors: Real world data from a mass-vaccination campaignECCO'22Year: 2022
Authors: Lev Zion, R.(1);Focht, G.(1);Lujan, R.(1);Mendelovici, A.(1);Friss, C.(1);Greenfeld, S.(2);Kariv, R.(3);Ben-Tov, A.(4,5);Matz, E.(6);Nevo, D.(7);Barak-Corren, Y.(8);Dotan, I.(9);Turner, D.(10);
(1)Shaare Zedek Medical Center, Department of Pediatric Gastroenterology, Jerusalem, Israel;(2)Maccabi Health Services and the Sackler Faculty of Medicine- Tel Aviv University, Medical Informatics, Tel-Aviv, Israel;(3)Maccabi Health Services and the Sackler Faculty of Medicine- Tel Aviv University, Gastroenterology, Tel-Aviv, Israel;(4)Maccabi Health Services and the Sackler Faculty of Medicine- Tel Aviv University, Institute for Research & Innovation, Tel-Aviv, Israel;(5)Dana-Dwek Children's Hospital- Tel-Aviv Sourasky Medical Center, Pediatric Gastroenterology, Tel-Aviv, Israel;(6)Leumit Health Services, Community Medicine, Tel-Aviv, Israel;(7)Tel-Aviv University, Department of Statistics and Operations Research, Tel-Aviv, Israel;(8)Boston Children's Hospital, Predictive Medicine Group, Boston, United States;(9)Rabin Medical Center and the Sackler Faculty of Medicine- Tel Aviv University, Gastroenterology, Petah Tikva, Israel;(10)Shaare Zedek Medical Center and the Hebrew University of Jerusalem, Department of Pediatric Gastroenterology, Jerusalem, Israel;
DOP27: Humoral immune response after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases treated with immunosuppressive therapy - a Target to B! studyECCO'22Year: 2022
Authors: Volkers , A.(1);Wieske , L.(2);van Dam , K.(2);Steenhuis , M.(3);Stalman , E.(2);Kummer , L.(2);van Kempen , Z.(4);Killestein , J.(4);Tas , S.(5);Boekel , L.(6);Wolbink , G.(6);Takkenberg , B.(1);Spuls , P.(7);Bosma , A.(7);Rutgers , B.(8);Verschuuren , J.(9);van Ouwerkerk , L.(10);van der Woude , D.(10);van Paassen , P.(11);Busch , M.(11);Brusse , E.(12);Hijnen , D.(13);ten Brinke , A.(3);Verstegen , N.(3);D'Haens , G.(1);van Ham , M.(3);Kuijpers , T.(14);Rispens , T.(3);Löwenberg , M.(1);Eftimov , F.(2); on behalf of the T2B! immunity against SARS-CoV-2 study group
(1)Amsterdam UMC- location AMC, Gastroenterology and Hepatology, Amsterdam, The Netherlands;(2)Amsterdam UMC- location AMC, Department of Neurology and Neurophysiology, Amsterdam, The Netherlands;(3)Sanquin, Department of immunopathology, Amsterdam, The Netherlands;(4)Amsterdam UMC- location VU University medical center, Department of Neurology, Amsterdam, The Netherlands;(5)Amsterdam UMC, Department of Rheumatology and Clinical Immunology, Amsterdam, The Netherlands;(6)Amsterdam Rheumatology and immunology Center- location Reade, Department of Rheumatology, Amsterdam, The Netherlands;(7)Amsterdam UMC- location Academic Medical Center, Department of Dermatology, Amsterdam, The Netherlands;(8)University Medical Center Groningen, Department of Rheumatology and Clinical Immunology, Groningen, The Netherlands;(9)Leiden University Medical Center, Department of Neurology, Leiden, The Netherlands;(10)Leiden University Medical Center, Department of Rheumatology, Leiden, The Netherlands;(11)Maastricht University Medical Center, Department of Nephrology and Clinical Immunology, Maastricht, The Netherlands;(12)Erasmus MC University Medical Center, Department of Neurology, Rotterdam, The Netherlands;(13)Erasmus MC University Medical Center, Department of Dermatology, Rotterdam, The Netherlands;(14)Amsterdam UMC- location AMC, Department of Pediatric Immunology- Rheumatology and Infectious Disease, Amsterdam, The Netherlands;
DOP28: Venous thromboembolism following discharge from hospital in patients admitted for Inflammatory Bowel DiseaseECCO'22Year: 2022
Authors: Harvey, P.(1);Coupland, B.(2);Mytton, J.(2);Trudgill, N.(3);De Silva, S.(4);
(1)The Royal Wolverhampton NHS trust, Department of Gastroenterology, Wolverhampton, United Kingdom;(2)University Hospital Birmingham, Healthcare Informatics, Birmingham, United Kingdom;(3)Sandwell and West Birmingham NHS Trust, Gastroenterology, Birmingham, United Kingdom;(4)Dudley Group NHS Trust, Gastroenterology, Birmingham, United Kingdom;
DOP29: A novel predictive scoring system of venous thromboembolism after surgery for Inflammatory Bowel Disease: A NSQIP-IBD registry analysisECCO'22Year: 2022
Authors: Cheong, J.Y.(1);Connelly, T.(1);Prien, C.(1);Jia, X.(1);Valente, M.(1);Bhama, A.(1);Lightner, A.(1);HolubarMD- MS, S.(1);
(1)Cleveland Clinic, Department of Colon & Rectal Surgery, Cleveland, United States;
DOP30: Long-term outcomes of Crohn’s perianal fistulas treatment: anti-TNF with surgical closure versus anti-TNF alone (PISA-II) - A patient preference RCTECCO'22Year: 2022
Authors: Meima - van PraagMD, E.(1);Stoker, J.(2);D'Haens, G.(3);Gecse, K.(4);Dijkgraaf, M.(5);Bemelman, W.(1);Buskens, C.(1);
(1)Amsterdam UMC, Surgery, Amsterdam, The Netherlands;(2)Amsterdam UMC, Radiology and Nuclear Medicine, Amsterdam, The Netherlands;(3)Amsterdam UMC, Gastroenterology and Hepatology, Gastroenterology and Hepatology, The Netherlands;(4)Amsterdam UMC, Gastroenterology and Hepatology, Amsterdam, The Netherlands;(5)Amsterdam UMC, Clinical Epidemiology- Biostatistics and Bioinformatics, Amsterdam, The Netherlands;
DOP31: Efficacy and safety of bone marrow-derived mesenchymal stem cells in refractory perianal fistulae in Crohn’s Disease: Results from a prospective monocentric studyECCO'22Year: 2022
Authors: Reenaers Dr, C.(1);Vieujean , S.(1);Coimbra , C.(2);Gillard , R.(3);Meunier , P.(3);Boutaffala , L.(1);Louis , E.(1);
(1)CHU Liège- Sart Tilman, Department of Gastroenterology, Liège, Belgium;(2)CHU Liège- Sart Tilman, Department of abdominal surgery, Liège, Belgium;(3)CHU Liège- Sart Tilman, Department of radiology, Liège, Belgium;
DOP33: Role of adherent and invasive E. coli in Crohn’s Disease: Lessons from the postoperative recurrence modelECCO'22Year: 2022
Authors: Buisson, A.(1);Sokol, H.(2);Hammoudi, N.(3);Nancey, S.(4);Treton, X.(5);Nachury, M.(6);Fumery, M.(7);Hébuterne, X.(8);Rodrigues, M.(9);Hugot, J.P.(10);Boschetti, G.(4);Stefanescu, C.(5);Wils , P.(6);Seksik, P.(2);Le Bourhis, L.(3);Bezault, M.(11);Sauvanet, P.(9);Pereira, B.(12);Allez, M.(3);Barnich, N.(9);
(1)University Hospital Estaing, Department of Gastroenterology- IBD Unit, Clermont-Ferrand, France;(2)AP-HP Saint-Antoine Hospital, IBD Unit, Paris, France;(3)AP-HP Saint-Louis Hospital, IBD Unit, Paris, France;(4)HCL-Lyon Sud, IBD Unit, Lyon, France;(5)AP-HP Beaujon Hospital, IBD Unit, Paris, France;(6)CHRU Lille, IBD Unit, Lille, France;(7)CHU Amiens, IBD Unit, Amiens, France;(8)CHU Nice, IBD Unit, Nice, France;(9)Université Clermont Auvergne, M2iSH, Clermont--Ferrand, France;(10)Centre de recherche sur l’inflammation- INSERM UMR 1149- Assistance Publique-Hôpitaux de Paris- Université de Paris, IBD Unit, Paris, France;(11)REMIND group, Administrative staff, Paris, France;(12)University Hospital Estaing, DRCI- Statistics Unit, Clermont-Ferrand, France;REMIND study group
DOP34: Comparison of the risk of clinical recurrence after ileocolonic resection for Crohn's Disease for modified Rutgeerts' score i2a and i2b categories: Individual patient data meta-analysisECCO'22Year: 2022
Authors: Riviere, P.(1);Pekow, J.(2);Hammoudi, N.(3);Wils, P.(4);De Cruz, P.(5);Wang, C.(6);Mañosa, M.(7);Ollech, J.(2);Allez, M.(3);Nachury, M.(4);Kamm, M.(5);Maya, A.(2);Ferrante, M.(8);Buisson, A.(9);Singh, S.(10);Laharie, D.(1);Momar, D.(11);Fumery, M.(12);
(1)Bordeaux University Hospital, Gastroenterology unit, Pessac, France;(2)University of Chicago, Gastroenterology, Chicago, United States;(3)Hôpital Saint-Louis, Gastroenterology, Paris, France;(4)Lille University Hospital, Gastroenterology, Lille, France;(5)The Austin Hospital, Gastroenterology, Melbourne, Australia;(6)Mount Sinai Hospital, Gastroenterology, New York, United States;(7)Hospital Germans Trias, Gastroenterology, Badalona, Spain;(8)Leuven University Hospitals, Gastroenterology, Leuven, Belgium;(9)Clermont Ferrand University Hospitals, Gastroenterology, Clermont Ferrand, France;(10)UC San Diego Health, Gastroenterology, San Diego, United States;(11)Amiens University Hospitals, Statistics, Amiens, France;(12)Amiens University Hospitals, Gastroenterology, Amiens, France;
DOP35: Increasing incidence of pouchitis among patients undergoing ileal pouch-anal anastomosis between 1996 and 2018: A population-based Danish cohort studyECCO'22Year: 2022
Authors: Barnes, E.(1);Allin, K.(2);Iversen, A.(2);Herfarth, H.(1);Jess, T.(2);
(1)University of North Carolina at Chapel Hill, Division of Gastroenterology and Hepatology, Chapel Hill, United States;(2)Center for Molecular Prediction of Inflammatory Bowel Disease- Aalborg University, Department of Clinical Medicine, Copenhagen, Denmark;
